- $694.40m
- $639.96m
- $279.58m
Annual income statement for Quantum, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
R2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 383 | 422 | 312 | 274 | 280 |
| Cost of Revenue | |||||
| Gross Profit | 158 | 143 | 125 | 110 | 103 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 392 | 440 | 340 | 319 | 364 |
| Operating Profit | -8.2 | -18.1 | -28.9 | -44.7 | -84.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 39.7 | -16.4 | -40.6 | -114 | -100 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 38.4 | -18.4 | -41.3 | -115 | -101 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 38.4 | -18.4 | -41.3 | -115 | -101 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -21.4 | -18.4 | -41.3 | -115 | -101 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -5.36 | -3.63 | -8.24 | -21.5 | -4.5 |